Clinicopathological Correlation of Glioma Patients with respect to Immunohistochemistry Markers: A Prospective Study of 115 Patients in a Tertiary Care Hospital in North India

BACKGROUND: With the incorporation of molecular subtyping in glioma patients in 2016 WHO classification, there is a need to understand the immunohistochemistry (IHC) marker expression in various glioma patients and to clinically correlate with various subgroups. OBJECTIVE: Aim of the study was to as...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahuja, Gitanshu, Gupta, Ashok, Jindal, Arpita, Jain, Gaurav, Sharma, Santosh, Kumar, Arvind
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751513/
https://www.ncbi.nlm.nih.gov/pubmed/35071070
http://dx.doi.org/10.4103/ajns.AJNS_377_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751513/
https://www.ncbi.nlm.nih.gov/pubmed/35071070
http://dx.doi.org/10.4103/ajns.AJNS_377_20

Ejemplares similares